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The short-rib polydactyly (SRP) syndromes are a heterogenous group of perinatal lethal skeletal disorders with polydactyly and
multisystem organ abnormalities. Homozygosity by descent mapping in a consanguineous SRP family identiﬁed a genomic region
that contained DYNC2H1, a cytoplasmic dynein involved in retrograde transport in the cilium. Affected individuals in the family
were homozygous for an exon 12 missense mutation that predicted the amino acid substitution R587C. Compound heterozygosity
for one missense and one null mutation was identiﬁed in two additional nonconsanguineous SRP families. Cultured chondrocytes
from affected individuals showedmorphologically abnormal, shortened cilia. In addition, the chondrocytes showed abnormal cytoskel-
etal microtubule architecture, implicating an altered microtubule network as part of the disease process. These ﬁndings establish SRP as
a cilia disorder and demonstrate that DYNC2H1 is essential for skeletogenesis and growth.Cilia are highly conserved microtubule-based organelles
that project from the cell surface into the extracellular
environment and play diverse roles in cellular motility,
sensory transduction, and signaling. Cilia consist of
a microtubule-based axoneme made of nine peripheral
microtubule doublets arranged around a central core;
motile cilia contain two central microtubules (9 þ 2),
whereas nonmotile or primary cilia do not (9 þ 0).1,2
During early stages of cilia formation, the centriolar vesicle
docks at the plasmamembrane to form the axonemal shaft
and basal body. Further elongation and maintenance of
the cilia is dependent on the dynamic process of intraﬂa-
gellular transport (IFT). IFT bidirectionally transports
ciliary cargo with the help ofmotors along the outermicro-
tubules of the axoneme. Anterograde movement of
axonemal precursors from the basal body to the distal tip
is driven by the heterotrimeric kinesin-II motor. Retrograde
transport from the distal tip to the basal body is accom-
plished by the cytoplasmic dynein 2 complex.
In humans and mice, ciliary dysfunction is associated
with a large spectrum of disorders,3–5 including defects in
a variety of proteins necessary for IFT as well as in compo-
nents of the primary cilia, basal body, and centrosome.
Many of these phenotypes include polydactyly, and
some include abnormal skeletogenesis. In particular,
some cases of asphyxiating thoracic dystrophy (ATD
[MIM 208500]) result from mutations in the gene encod-
ing the anterograde transport protein IFT806 (MIM
611177). About two-thirds of patients with Ellis-van Cre-
veld (EVC [MIM 225500]) syndrome have mutations ineither EVC1 (MIM 604831) or EVC27–9 (MIM 607261),
and the Evc1 gene product has been localized to the ciliary
basal body in mouse chondrocytes, where it participates in
hedgehog signal transduction.10
The short-rib polydactyly syndromes are among the
most frequent autosomal-recessive osteochondrodyspla-
sias.11 Four distinct types (SRP I [Saldino-Noonan type
(MIM 263530)]; SRP II [Majweski type (MIM 263520)];
SRP III [Verma-Neumoff type (MIM 263510)]; and SRP IV
[Beemer type (MIM 269860)]) are recognized, and the
current nosology of the osteochondrodysplasias classiﬁes
types I and III together.12 However, many cases defy classi-
ﬁcation and demonstrate transitional ﬁndings between the
types, suggesting that SRP could be considered a single
group of disorders with a spectrum of variable phenotypic
expression.13–16 SRPs manifest extremely shortened long
bones, a small, narrow thorax, and frequent pre- and post-
axial polydactyly. Other multisystem anomalies, including
brain and cardiacmalformations (including situs inversus),
polycystic kidneys, gastrointestinal and genitourinary
atresia, and occasional sex reversal, are also observed.
Although genetically distinct in some instances,17 the
SRPs share phenotypic and radiographic ﬁndings with
ATD and EVC, supporting the hypothesis that these
diseases comprise a family of disorders that may be func-
tionally related.
Under an IRB-approved protocol for human subjects, we
ascertained a consanguineous family (International Skel-
etal Dysplasia Registry reference number R01-314) with
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a diagnosis of SRP type III was assigned, phenotypic anal-
ysis showed intrafamilial variability. At term, the proband
(R01-314A, II-2) had shortened horizontal ribs, a trident
pelvis, and metaphyseal spikes at the lateral ends of the
femora, with neither polydactyly nor other organ system
abnormalities (Figures 1A–1C). The other affected fetuses,
R01-314B (II-3) (Figure 1F), R01-314C (II-4), and R01-
314F (II-5) (20 weeks, 16 weeks, and 11 weeks gestational
age, respectively) showed similar radiographic ﬁndings
but also had postaxial polydactyly of the hands and feet.
For R01-304B, C, and F (II-3, 4, and 5), prenatal ultrasound
did not identify abnormalities in the brain, heart, kidneys,
or liver.
Two nonconsanguineous SRP type III cases were also
studied. Case R00-097A (II-1) exhibited preaxial polydac-
tyly and shortened long bones with some metaphyseal
spikes (Figures 1E and 1H). Case R06-237A (II-1) had similar
radiographic ﬁndings but exhibited postaxial rather than
pre-axial polydactyly (Figures 1D and 1G). Abnormalities
of the visceral organs were not noted in these cases.
To deﬁne the molecular basis of SRP, we used whole-
genome SNP analysis to identify regions of homozygosity
that were greater than 1 Mb and were shared among the
affected individuals in the consanguineous family but
not shared with the unaffected sibling. SNP data were
generated with the NSPI array from the GeneChip Human
Mapping 500K Array Set (Affymetrix) in the UCLAMicroar-
ray Core facility according to manufacturer-recommended
protocols. Three intervals, totaling approximately 60.7 Mb,
were identiﬁed on chromosomes 1, 11, and 16 (Figure 2).
Under the hypothesis that SRP would result from a defect
in cilia function, genes with a possible role in cilia were
identiﬁed within these intervals via the cilia proteome data-
base (see URLs below). One gene, DYN2CH1 (MIM 603297)
at chromosome11q21-22was aparticularly attractive candi-
date because homozygosity for either point mutations or
null mutations in the mouse ortholog resulted in polydac-
tyly.18–20 DYNC2H1 encodes a 4,307 amino acid ciliary
protein that has a predicted molecular mass of approxi-
mately 492 kD and plays a role in retrograde transport in
the cilium.21
The 90 coding exons of DYNC2H1 were ampliﬁed by
PCR (oligonucleotide sequences; see Table S1 in the
Supplemental Data available online), and the sequences
of the PCR products were determined by bidirectional
sequence analysis (MC Labs) and compared with the refer-
ence sequence for DYNC2H1 with Sequencher (Gene Co-
des). Nucleotides were numbered according to the mRNA
sequence, starting from the A of the ATG initiation codon.
The affected individuals in family R01-314 were all homo-
zygous for an exon 12 missense mutation, c.1759C > T,
predicted to lead to the amino acid substitution p.R587C
(Figure 3A). This residue is conserved amongDYNC2H1 or-
thologs from Homo sapiens through Caenorhabditis elegans.
The unaffected parents were both heterozygous for the
mutation, and the unaffected sibling carried only the
wild-type sequence. The sequence change was not foundThe Amamong 214 control chromosomes, indicating that it is
not a common polymorphism in the population.22
Compound heterozygosity for DYNC2H1mutations was
identiﬁed in the two nonconsaguineous SRP type III cases.
In case R00-097A (II-1), mutations in exons 41 (c.6614 G>
A) and 53 (c.8512 C > T), predicted to lead to the amino
BA
C D E
F G H
Figure 1. Radiographic Hallmarks of SRP
(A) R01-314A, newborn. A/P view showing the characteristic trident
pelvis (arrow) and the long narrow chest with horizontal ribs.
(B) R01-314A, newborn. The arrow identifies the distal end of the
femur, showing metaphyseal spikes.
(C) R01-314A, newborn. There is no polydactyly in the hand
(arrow).
(D) R06-237A, 20 weeks gestation. The arrow identifies metaphy-
seal spikes of the distal humerus.
(E) R00-097A, 20 weeks gestation. The arrow identifies the preaxial
polydactyly of the foot.
(F) R01-314B, 20 weeks gestation. The arrow identifies postaxial
polydactyly of the foot.
(G) R06-237A, 20 weeks gestation. The arrow identifies postaxial
polydactyly of the foot.
(H) R00-097A, 20 weeks gestation. The lower extremity shows
a shortened femur, tibia, and fibula with metaphyseal spikes
(arrow).erican Journal of Human Genetics 84, 542–549, April 10, 2009 543
Figure 2. Homozygosity by Descent Mapping
(A) Homozygosity by descent mapping in family R01-314. All intervals of homozygosity shared among the four affected family members of
family R01-314 are plotted across the genome. Chromosomal position is indicated on the x axis, and length of the homozygous interval is
plotted on the y axis such that height of the filled-in graphic indicates the length of the measured homozygous intervals in centimorgans.
Physical distances: chromosome 1 (rs11209979-rs4656100; 71,153,296-85,028,578bp), chromosome 11 (rs 10501715-rs1029278;
86,043.913-119,363,025bp), and chromosome 16 (rs12924823-rs12928078; 10,726,309-24,280,658bp).acid substitution p.R2205H, and a nonsense mutation,
p.R2838X, were found (Figure 3B). These sequence
changes were not found among 210 control chromosomes.
For case R06-237A (II-1), a change of two consecutive base
pairs was identiﬁed in exon 5 (c.624-625 GT>AA); the ﬁrst
nucleotide change altered the last base of codon 208
without changing the encoded amino acid, and the second
change predicted the amino acid substitution F209I
(Figure 3C). This sequence change was not found among
210 control chromosomes. The second mutation, which
was not found among 210 control chromosomes, altered
the splice donor in intron 33 (c.IVS 33þ1, G > T). To
examine the consequences of the splice donor mutation
on splicing, we carried out RT-PCR on RNA extracted
from cultured chondrocytes. Primary chondrocytes were
isolated from distal femurs of affected individuals or age-
matched normal controls by incubation of cartilage with
0.03% bacterial collagenase II (Sigma-Aldrich) at 37C for
8 hr. Liberated chondrocytes were propagated in DMEM
with 10% FBS. RNA was isolated with Trizol (Invitrogen)
according to standard protocols. The RT-PCR experiments
demonstrated that the mutation did not result in the
skipping of exon 33 (data not shown). However, when
primers E4F: 50 TGAGTTCCAGTTTTGGATAGAACA30 and
E6R: 50ATTTTTCCATGGATGAGGAACATA30 were used for
amplifying a 512 bp pair product spanning exons 4-6,
sequence analysis of the resulting RT-PCR products con-
taining exon 5 showed that most of the transcripts were
derived from the c.624-625 GT > AA missense allele
(Figure 4A). These data were consistent with loss of the544 The American Journal of Human Genetics 84, 542–549, April 10exon 5 wild-type sequence derived from the allele with
the splice-donor mutation. The diminished abundance of
the products of the splice-donormutant allele was partially
reversed when the cells were incubated with cyclohexa-
mide (Sigma-Aldrich) at a concentration of 100 mg/ml at
37C for 8 hr (Figure 4B), consistent with loss of the tran-
scripts by nonsense-mediated decay.23 To corroborate
these results, we performed quantitative PCR analysis for
DYNC2H1 chondrocyte cDNA in triplicate (SABioscience)
(Stragene, MX3005P). Results showed an almost 50%
reduction in DYNC2H1 cDNA levels in R06-237A
compared to controls (Figure 4C). We thus conclude that
the intron 33 mutation in R06-237A (c.IVS 33þ1, G > T)
results in a null allele.
On the basis of the function of DYNC2H1 and the
abnormalities seen in the mouse mutants,18–20 the SRP
mutations identiﬁed would be predicted to lead to
morphologically abnormal cilia that could be visualized
by scanning electron microscopy. To examine the cilia,
we seeded primary chondrocytes on 13 mm round Ther-
manox coverslips. After a 24 hr incubation in DMEM
with 10% FBS, conﬂuent cells were serum starved in
DMEM with 0.5% FBS for 48 hr. Cells were ﬁxed in 2.5%
glutaraldehyde/DMEM for 40 min, washed with 0.1 M
sodium phosphate buffer, and ﬁxed in Karnovsky’s ﬁxative
(2% paraformaldehyde, 2.5% glutaraldehyde, and 0.1 M
sodium phosphate buffer) for 1.5 hr. After ﬁxation, cells
were washed with 0.1 M sodium phosphate buffer,
dehydrated through a graded ethanol series, and processed
for critical point drying and coating. Samples were imaged, 2009
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Figure 3. DYNC2H1 Mutation Analysis
Sequencing chromatograms demonstrating mutations in DYNC2H1 in the three families studied: (A) R01-314, (B) R00-097, and (C) R06-
237. (D) Diagram of the DYNC2H1 molecule with the locations of the protein sequence changes predicted by the mutations. The scale
below indicates the length of the protein. AAA, ATP binding and hydrolysis domains; C domain, carboxyl-terminal domain; aa, amino acid.with a Cambridge 360 scanning electron microscope (Carl
Zeiss, Thornwood, NY). The cilia in mutant cultured chon-
drocytes from case R01-314B were shortened and had
bulbous distal ends (Figures 5B and 5D) in comparison to
controls (Figures 5A and 5C). Although shortening of all
mutant cilia was observed, some chondrocytes had no
discernable cilia projecting from their cell surfaces.
Additional structural information for the chondrocyte
cilia was provided by ﬂuorescence microscopy. For these
studies, primary chondrocytes were seeded on four-well
chamber slides (Lab-Tek). After 24 hr of growth, conﬂuent
cells were serum starved in DMEMwith 0.5% FBS for 48 hr.
Cells were washed with ice-cold PBS, ﬁxed in 4% parafor-
maldehyde for 15 min at room temperature, permeablizedThe Amwith PBS plus 0.1% Tween-20, blocked with 10% goat
serum (Zymed) for 1 hr, and incubated with monoclonal
acetylated a-tubulin antibody (1/1000, Clone 6-11B-1,
Sigma-Aldrich) and g-tubulin antibody (1/500, T3559,
Sigma-Aldrich) diluted in 1% goat serum/PBST overnight
at 4C. Primary antibodies were detected with Alexa Fluor
568 goat anti-mouse antibody (Molecular Probes, Invitro-
gen) diluted 1/400 and Alexa Fluor 488 goat anti-rabbit
antibody (Molecular Probes, Invitrogen) in 1% goat
serum/PBST at room temperature for 1 hr. Slides were cov-
erslipped with Vectashield and DAPI. Confocal images
were taken sequentially on a Leica TCS-SP2 AOBS inverted
confocal microscope (Mannheim, Germany) equipped
with a 405 nm blue diode laser, argon laser (488 nm blueerican Journal of Human Genetics 84, 542–549, April 10, 2009 545
excitation: JDS Uniphase), and three helium neon lasers
(543 nm, green excitation; 594 nm, near-red excitation;
and 633 nm far-red excitation). As observed by SEM,
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Figure 4. c. IVS33þ1 G > T Allele Found in R06-237 Leads to
Nonsense-Mediated Decay
Sequencing chromatograms of RT-PCR products from R06-237A
chondrocytes generated in the absence (A) and presence (B) of
cycloheximide. (C) Quantitative PCR analysis showed an almost
50% reduction in DYNC2H1 transcripts in R06-237A chondrocytes
compared to stage-matched control chondrocytes. Vertical bars
indicate the standard deviation.
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Figure 5. p.R587C Allele Found in R01-314 Produces
Abnormal Primary Cilia in Chondrocytes
(A) Cilia visualized by scanning electron microscopy showed nor-
mally shaped cilia in control chondrocytes. The boxed area is
shown at higher magnification in (C). (B) Cilia present on chondro-
cytes from case R01-314B were short and had an abnormal bulge
at the tip of the axoneme. The boxed area is shown at higher
magnification in (D).546 The American Journal of Human Genetics 84, 542–549, April 10immunoﬂuorescence for acetylated a-tubulin, a known
marker for cilia, in cultured chondrocytes from cases
R01-314B and R06-237A demonstrated that, in compar-
ison to control cells (Figures 6A and 6D), the cilia were
shorter and abnormally shaped and had a bulbous tip
(Figures 6, 6C, 6E, and 6F). Distinct from the SEM ﬁndings,
the acetylated a-tubulin antibody identiﬁed abbreviated,
cilia-like structures in all mutant chondrocytes (Figures
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Figure 6. SRP Chondrocytes Have Abnormal Primary Cilia and
Increased Levels of Acetylated a-tubulin
(A and D) Immunofluorescence for acetylated a-tubulin (red) and
DAPI (blue) in primary chondrocytes shows normal presentation of
cilia in control cells. Chondrocytes from R01-314B (B and E) and
R06-237A (C and F) show abnormal cilia and increased amounts
of cytoplasmic acetylated a-tubulin. (D–F) Higher-magnification
views of the boxed regions in (A)–(C). Cilia length measured an
average of 3.2 5 0.57 mm in control cells and 1.9 5 0.44 mm in
SRP chondrocytes (p, 0.01, Student’s t test). (G–I) Immunofluores-
cence for acetylated a-tubulin (red), g tubulin (green), and DAPI
(blue) shows the presence of a basal body in both control and SRP
chondrocytes. (J) Immunoblot analysis of acetylated a-tubulin
expression in control, R01-314A, and R06-237B chondrocytes
showed an increase of acetylated a-tubulin expression in mutant
chondrocytes compared to the control. b-actin was used as
a protein loading control. (K) Quantitation of the ratio of acety-
lated a-tubulin relative to b-actin from the immunoblots (n ¼ 4)
demonstratied about a 2-fold increase in the relative level of acet-
ylated a-tubulin in mutant chondrocytes compared to the normal
control. Vertical bars indicate the standard deviation., 2009
6B and 6C). Cilia length was an average of 3.25 0.57 mm
in control cell and 1.95 0.44 mm in SRP chondrocytes (p<
0.01). Interrogation with g-tubulin antibody (Figures
6G–6I) identiﬁed the basal body in SRP cilia and conﬁrmed
that the bulbus projection seen by SEM in the axoneme
was at the distal tip (Figures 6H and 6I). Together, these
data suggest that the early stages of cilia formation, which
involve docking of the basal body to the plasma
membrane, remained intact, whereas elongation and/or
maintenance of the axoneme by IFT to form the mature
primary cilium was abnormal.
In addition to the structural defect in the cilia, the immu-
noﬂuorescence studies of SRP chondrocytes showed both
abnormally fragmented and increased amounts of cyto-
plasmic acetylated a-tubulin (Figures 6B, 6C, 6E, 6F, 6H,
and 6I) in comparison to controls (Figures 6A, 6D, and
6G), consistent with a defect in cytoskeletal microtubule
architecture. To examine these ﬁndings quantitatively, we
carried out immunoblot analysis for acetylated a-tubulin
(Figure 6J). Proteins from primary chondrocytes were ex-
tracted in RIPA buffer and resolved under reducing condi-
tions by electrophoresis on a 10% SDS PAGE gel. Proteins
were transferred to a nitrocellulose membrane (BioRad)
and blocked for 1 hr in 5% milk/TBS and 0.1% Tween-20
(TBST). Membranes were probed with monoclonal acety-
lated tubulin antibody (Clone 6-11B-1, Sigma-Aldrich)
diluted 1/2000 or b-actin antibody (Cell Signaling) diluted
1/1000 in 5% BSA/TBST overnight at 4C. Membranes
were washed in TBST and incubated with HRP-conjugated
goat anti-mouse secondary antibody (Immuno Pure,
Thermo Science) diluted 1/5000 in 1% milk/TBST for 1 hr
at room temperature. Immunoreactivity was detected
with a chemiluminescence detection system (Cell Signaling
Technology). Immunoblots were performed in quadrupli-
cate, and quantitation of band intensity demonstrated an
approximately 2-fold increase in acetylated a-tubulin in
the SRP samples relative to the control (Figure 6K).
Microtubules exhibit dynamic instability in that they
build and disassemble in response to the needs of the
cell.24 Alterations in stabilization of the microtubules
through acetylation of a-tubulin and destabilization by
a-tubulin tyrosination are known to disrupt cellular func-
tions.25 In Dictyostelium, the dynein complex stabilizes
interphase microtubule arrays, and disruptions result in
a disorganized microtubule cytoskeleton.26,27 Because the
cytoplasmic dyneins in the basal body of the cilium have
a microtubule-binding domain and interact with microtu-
bules via the microtubule-organizing center of the centro-
some, the microtubule structural abnormalities identiﬁed
in SRP raise the possibility that loss of DYNC2H1 function
could affect movement of organelles and transport of crit-
ical cargo necessary for signal transduction and skeletal
development.
Cytoplasmic dyneins are composed of heavy-chain
homodimers with differing accessory subunits. All dyneins
share a common structure consisting of an amino-terminal
stem region, a linker region, and six identiﬁable ATP-The Ambinding and -hydrolysis domains (AAA), and a stalk
between AAA domains 4 and 5 is implicated in microtu-
bule binding (Figure 3D).28,29 The amino-terminal stem
of the molecule is involved in homodimerization and
binding of accessory units to form the complex that binds
cargo. The F209I and R587C substitutions found in the SRP
cases alter the amino-terminal stem and thus may interfere
with these functions. The R2205H substitution is localized
in an AAA unit and could hinder ATP hydrolysis and gener-
ation of adequate force for microtubule movement,
although the exact mechanism by which dyneins convert
the energy released by ATP hydrolysis into force is not fully
understood.29 The nonconsanguineous cases were both
compound heterozygotes for one missense and one null
mutation. It is therefore apparent that synthesis of inade-
quate amounts of the gene product along with expression
of a mutant protein produces SRP in these cases. We spec-
ulate that homozygosity for two null alleles would result in
early embryonic lethality but that a range of phenotypes
could result from a combination of a null mutation and
a variety of missense mutations in this large and complex
molecule.
The abnormalities in SRP are primarily related to the
effect on the skeleton, reﬂecting an essential role for
DYNC2H1 in cilia function in cartilage. Chondrocyte cilia
are embedded in a rich extracellular matrix that includes
growth factors and signalingmolecules that signal through
cell surface receptors30 to organize the development of
a properly patterned skeleton capable of promoting linear
growth. The ciliary abnormalities in SRP suggest that cilia
are critical to chondrocytes’ ability to detect and transmit
these signals, as well as mechanosensory signals,31 in
that they provide a link through which the cell can
monitor the extracellular environment and translate cues
that facilitate cellular processes important for chondrocyte
proliferation.32–34 Identiﬁcation of the speciﬁc signaling
pathways or cargos altered in SRP will aid in determining
how defects in DYNC2H1 produce their profound effect
on the skeleton. Our ﬁndings ﬁrmly establish SRP as
a member of the increasingly large group of cilia disorders
and reveal an essential function for DYNC2H1 in skeleto-
genesis and growth.
Supplemental Data
Supplemental Data include one table and are available with this
article online at http://www.ajhg.org/.
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